Clinical Trial Update: A Study of BGM0504 in Chinese Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study of BGM0504 in Chinese patients with Type 2 diabetes mellitus has completed the study status according to the clinical trials listing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED